Neurelis
Encinitas, US
Biotech
Founders & leadership
DF
David F. HaleDirector
CC
Cam C. GarnerDirector
CC
Craig C. ChamblissExecutive Officer, Director
YC
Yong C. ZhangDirector
KC
Kevin C. LiDirector
Reported raises · per SEC filings
Form D private placements$114.8MraisedMar 2021 · 9 investors · Biotechnology
Rule 506(b)$42.1MraisedOct 2020 · 26 investors · Biotechnology
Rule 506(b)$40.5MraisedNov 2018 · 15 investors · Biotechnology
Rule 506(b)$5.2MraisedAug 2018 · 11 investors · Biotechnology
Rule 506(b)$15MraisedDec 2017 · 2 investors · Biotechnology
Rule 506(b)$1.5MraisedJul 2015 · 1 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.